Friday, February 9, 2018 | 11:30 a.m. to 1:30 p.m.
The life sciences are innovating at a unprecedented pace, is government policy keeping up or holding us back?
Whether it’s artificial intelligence or new gene therapies that can potentially cure cancer, we are at a pivotal moment in the evolution and adoption of new technologies that will fundamentally change how we live, work, and treat illness. Access to these breakthrough technologies is key to our future health and prosperity and Canadians at the cutting edge of many of these new discoveries expect no less. But as Pamela Fralick, President of Innovative Medicines Canada explains, proposed policy changes to Canada’s patented drug pricing regime will have profound implications for Canadian healthcare and life sciences for decades to come.
– Lunch will be served –
Individual seat: $89 +HST
Table (seats 10): $800 +HST
Individual seat: $110 +HST
Table (seats 10): $990 +HST
– For information about accessibility, please email firstname.lastname@example.org
– Dietary restriction notes and meal requests must be submitted to email@example.com by Friday, February 2, 2018.
*The views expressed on the Economic Club platform are not that of the Economic Club or its affiliates but of the speakers alone and the organizations they represent*
Pamela Fralick is an experienced leader who has been fostering positive change in Canada’s health sector for decades. Throughout her career, Ms. Fralick has distinguished herself in a variety of senior roles. A convener and innovator, Ms. Fralick is one of Canada’s leading, compassionate voices in the health sector. As the President of Innovative Medicines Canada, Ms. Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need, when they need them.
Prior to joining Innovative Medicines Canada, Ms. Fralick was President and CEO of the Canadian Cancer Society, Canada’s largest health charity, where she oversaw a three-year process of intense transformation, resulting in historic changes to the operational and governance structures of the organization.
Ms. Fralick previously served as president and CEO of the Canadian Healthcare Association (CHA) and as CEO of the Canadian Physiotherapy Association. At both Associations, Ms. Fralick led organizational initiatives designed to enhance sustainability and improve outcomes for the associations, their members and stakeholders. Ms. Fralick has also held senior positions with the Canadian Centre on Substance Abuse and Health Canada’s Alcohol and Other Drugs Unit.
True to her commitment to the health and well-being of Canadians, Ms. Fralick has served on numerous prestigious boards and collaboratives across Canada. She was Chair of the Health Action Lobby (HEAL) and Co-chair the Canadian Coalition for Public Health in the 21st Century (CCPH21). She has been active in many organizations as a senior volunteer, including the Centre for Addiction and Mental Health, the University of Ottawa Institute of Mental Health Research, Triathlon Canada and the International Triathlon Union. She is currently on the board of Outward Bound Canada (Chair) and the Canada Dance Festival (Past Chair).
Ms. Fralick has a BA in French and psychology and an MA in developmental psychology from Carleton University, as well as a Master of Public Administration (MPA) from Queen’s University. She also holds an ICD.D designation. She is trilingual – in English, French and German – and is an accomplished artist and athlete.
Fairmont Royal York – 100 Front Street West, Toronto, Toronto